Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xuxin
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Xuxin Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, and production of pharmaceutical raw materials and intermediates. The company is engaged in providing comprehensive solutions for the life sciences sector, with an emphasis on chemical synthesis for pharma applications. There are no publicly disclosed clinical results or late-stage drug programs.
- Modalities
- Small moleculesPharmaceutical intermediates
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Xuxin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuxin.